Evidence map›Paper›PMID 31681266›Full record

ArticleFrontiers in immunology2019

Exploring

Cheryl A Kivisi, Michelle Muthui, Martin Hunt, Greg Fegan, Thomas Dan Otto, George Githinji, George M Warimwe, Richard Rance, Kevin Marsh, Peter C Bull and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Analysis of var Gene Transcription Pattern Using DBLα Tags.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Cheryl A KivisiKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Michelle MuthuiKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Martin HuntWellcome Sanger Institute, Cambridge, United Kingdom.
Greg FeganKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Thomas Dan OttoWellcome Sanger Institute, Cambridge, United Kingdom.
George GithinjiKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
George M WarimweKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Richard RancePwani University Biosciences Research Centre, Pwani University, Kilifi, Kenya.
Kevin MarshKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Peter C BullKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Abdirahman I AbdiKEMRI Wellcome Trust Research Programme, Kilifi, Kenya.
Kenya Medical Research Institute · KEWellcome Sanger Institute · GBPwani University · KE

Funding

Wellcome Trust 084535Wellcome Trust 084538Wellcome Trust 209289
6 · The paper itself

Abstract

In sub-Saharan Africa, children below 5 years bear the greatest burden of severe malaria because they lack naturally acquired immunity that develops following repeated exposure to infections by

Indexed as

Antigenic VariationAntibodies, ProtozoanAntigens, ProtozoanErythrocytesFemaleGene Expression RegulationHumansInfantInfant, NewbornKenyaMalaria, FalciparumMalePlasmodium falciparumProtozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanProtozoan Proteinsageinfantsmalariamaternal antibodiesvar gene expression

Identifiers

PMID31681266
PMCPMC6798654
OpenAlexW2979347160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.